These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1955520)

  • 1. A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism.
    Heldin NE; Gustavsson B; Westermark K; Westermark B
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1374-6. PubMed ID: 1955520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.
    Bahn RS; Dutton CM; Heufelder AE; Sarkar G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):256-60. PubMed ID: 7508946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules.
    Syrenicz A; Kurzawski G; Ciechanowicz A
    Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the TSH receptor as cause of congenital hyperthyroidism.
    Schwab KO; Söhlemann P; Gerlich M; Broecker M; Petrykowski W; Holzapfel HP; Paschke R; Grüters A; Derwahl M
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():124-8. PubMed ID: 8981019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5.
    Karges B; Krause G; Homoki J; Debatin KM; de Roux N; Karges W
    J Endocrinol; 2005 Aug; 186(2):377-85. PubMed ID: 16079263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [From gene to disease; thyroid stimulating hormone receptor, hyperthyroidism and hypothyroidism].
    Wiersinga WM
    Ned Tijdschr Geneeskd; 2001 May; 145(18):869-71. PubMed ID: 11379397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
    Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
    J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic non-autoimmune hyperthyroidism.
    Bircan R; Miehle K; Mladenova G; Ivanova R; Ivanova R; Sarafova A; Borissova AM; Lüblinghoff J; Paschke R
    Exp Clin Endocrinol Diabetes; 2008 Jun; 116(6):341-6. PubMed ID: 18528812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism.
    Biebermann H; Schöneberg T; Hess C; Germak J; Gudermann T; Grüters A
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4429-33. PubMed ID: 11549687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning of the cat TSH receptor and evidence against an autoimmune etiology of feline hyperthyroidism.
    Nguyen LQ; Arseven OK; Gerber H; Stein BS; Jameson JL; Kopp P
    Endocrinology; 2002 Feb; 143(2):395-402. PubMed ID: 11796491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene.
    Holzapfel HP; Wonerow P; von Petrykowski W; Henschen M; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3879-84. PubMed ID: 9360555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutively activating mutations of the thyrotropin receptor and thyroid disease.
    Führer D; Holzapfel HP; Wonerow P; Paschke R
    Eur J Med Res; 1996 Jul; 1(10):460-4. PubMed ID: 9438142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation.
    Arturi F; Chiefari E; Tumino S; Russo D; Squatrito S; Chazenbalk G; Persani L; Rapoport B; Filetti S
    J Endocrinol Invest; 2002 Sep; 25(8):696-701. PubMed ID: 12240901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of the TSH receptor.
    Duprez L; Parma J; Van Sande J; Rodien P; Sabine C; Abramowicz M; Dumont JE; Vassart G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():295-302. PubMed ID: 10698593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged inappropriate TSH suppression during hypothyroidism after thyroid ablation in a patient with nonautoimmune familial hyperthyroidism.
    Jaeschke H; Eszlinger M; Lueblinghoff J; Coslovsky R; Paschke R
    Horm Metab Res; 2011 Jun; 43(7):500-4. PubMed ID: 21590647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism.
    Nwosu BU; Gourgiotis L; Gershengorn MC; Neumann S
    Thyroid; 2006 May; 16(5):505-12. PubMed ID: 16756474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R).
    Pohlenz J; Pfarr N; Krüger S; Hesse V
    Acta Paediatr; 2006 Dec; 95(12):1685-7. PubMed ID: 17129985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.